Optura Raises $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures

May 15, 2026
Optura has secured $17.5 million in Series A funding led by Salesforce Ventures, with participation from Echo Health Ventures and others, to expand its ROAI platform for measuring AI investment value in healthcare.

Optura has raised $17.5 million in Series A funding led by Salesforce Ventures, with participation from Echo Health Ventures, Susa Ventures, Matrix Partners, and HC9 Ventures, announced in a press release. The new round brings Optura’s total funding to more than $25 million.

Optura’s platform, called ROAI (Return on AI Investment), helps healthcare organizations measure and manage the value of their AI initiatives. It allows users to assess AI business viability, prioritize investments, and track performance and returns through a unified dashboard. The company reports that more than $2 billion in AI initiatives are currently managed on the platform, with $120 million in tracked value.

Founded in 2025, Optura works with enterprise health plans and providers such as Independence Blue Cross, Prime Therapeutics, and Ardent Health. With the new funding, the company plans to expand its AI capabilities, grow its platform teams, and scale large language model partnerships.

The ROAI platform maps organizational data into a unified knowledge layer, ranks AI use cases based on readiness and cost, and simulates projected returns before deployment. It then tracks outcomes in real time to provide visibility into AI performance across the enterprise.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.